Geron Corporation (GERN) - Latest Market Data

Price & Market Data

Price: $1.53

Daily Change: +$0.02 / 1.31%

Range: $1.47 - $1.57

Market Cap: $974,484,544

Volume: 3,262,307

Performance Metrics

1 Week: -5.56%

1 Month: 26.45%

3 Months: -12.07%

6 Months: -61.56%

1 Year: -69.94%

YTD: -56.78%

Company Details

Employees: 229

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Selected stocks

Maywood Acquisition Corp. (MAYA)

Wintrust Financial Corporation - Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Prefer (WTFCN)

Meta Platforms, Inc. (META)